论文部分内容阅读
神经胶质瘤是临床上多发的颅内原发肿瘤,其中恶性胶质瘤具有分化程度低、细胞增殖活跃、侵袭性强等特点。目前的临床治疗手段与预后均不理想,外科手术不能完全切除,肿瘤对放疗和化疗呈现抵抗,肿瘤复发和转移的病例多见。在手术加放、化疗治疗后,中位生存期仅14.6个月,五年生存率不到5%,因此恶性胶质瘤是对健康危害极大的肿
Glioma is clinically multiple primary intracranial tumors, of which malignant glioma has a low degree of differentiation, active cell proliferation, aggressive and so on. The current clinical treatment and prognosis are not ideal, surgery can not be completely removed, the tumor showed resistance to radiotherapy and chemotherapy, tumor recurrence and metastasis of cases more common. After surgery and radiotherapy and chemotherapy, the median survival time is only 14.6 months and the five-year survival rate is less than 5%. Therefore, malignant gliomas are swollen to health